Table 2 presents the associations between TGF-β1 concentrations in patients with early-onset CAD and clinical parameters, including history of diabetes, hypertension, presence of metabolic syndrome, myocardial infarction, impaired ventricular function, and left ventricular hypertrophy. This evidence concerns the gene TGFB1 and diabetes mellitus.